To initiate basic research in the pharma colleges across the country, ACG Worldwide Chairman Ajit Singh and Pam Glatt Pharma Technologies Pvt Ltd CEO, Dr Shirish Dhande announced the launch of Quest Series and Mini Quest series in Bench Top and Table Top models for R&D scale segment at the inauguration of a new manufacturing facility dealing in pilot scale fluid beds and tablet coating equipment at Shirwal, Pune.

According to Dr Shirish Dhande, CEO, Pam Glatt Pharma Technologies Pvt Ltd, "Quest FB, Quest TC, Miniquest F and Miniquest T R&D scale equipment will help the pharmacy college students to test the technology with their own hands and bridge the yawning gap between theory and practice. It will help them build confidence and gain a foot hold in the pharma industry which is today witnessing technological advancements with a rapid pace."

Spread on an area of eight acre, the facility jointly set up by ACG Worldwide and Pam Glatt Pharma Technologies Pvt Ltd.  manufactures pilot scale fluid beds and tablet coating equipment.

There is a lot of investment made by the pharma companies in India in latest technology for improving the quality of medicines and making new variants of the product. This has been possible by the technologies accessible to the pharma industry from the tools given through pharma and allied machinery. Echoing his views on the occasion, Ajit Singh said that the success of such technologies is evident from the fact that our business accounts for 70 per cent of repeat orders from the clients. There are invisible costs also associated with the pharma process technologies which is attributed to the R&D projects successfully conducted by our group of 140 experts including designers, technologists and scientists.

Citing the achievement of Dr Yusuf Hamied founder of Cipla in the development and pricing of AIDS medicine of high quality which led to saving of 10 million lives in Africa, Ajit Singh concluded, "We should take forward our commitment as being a front runner in manufacturing formulation products of standard global quality because pharma and allied machinery largely represents the solid dosage formulations segment. It has therefore been understood that with making generic production of high quality the pharma and allied machinery is dealing in very high technology to make affordable healthcare to the world."